| Market Cap | 717.57K | P/E | - | EPS this Y | - | Ern Qtrly Grth | 185.40% |
| Income | -2.97M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -21.00% |
| Sales | -2.08k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -9.00% |
| Dividend | N/A | Price/Book | 2.14 | EPS next 5Y | - | 52W High Chg | -80.00% |
| Recommedations | - | Quick Ratio | 0.65 | Shares Outstanding | 20.92M | 52W Low Chg | 72.00% |
| Insider Own | 1.63% | ROA | -46.13% | Shares Float | 20.63M | Beta | 0.77 |
| Inst Own | 0.21% | ROE | -286.37% | Shares Shorted/Prior | -/- | Price | 0.03 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 14,312 | Target Price | - |
| Oper. Margin | 72,550.56% | Earnings Date | - | Volume | 13,609 | Change | -2.00% |
Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.
